Trial Site Detail

 

Drug:	Nilotinib or Imatinib
Trial:	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

The Cancer Institute/National University Hospital       Singapore , 119074 Singapore

 

Principal Investigator:	Yong W. Peng, MD
Contact:	Yong W. Peng, MD +65 6772 4670 wei_peng_yong@nuh.com.sg
Activation Status of this Site:	Closed
Notes about this Site:
The Cancer Institute/National University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.